Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations.

doi:10.1007/s00415-013-7187-5

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations.

Journal of neurology - 1 Jan 2014

Di Toro Mammarella L, Mignarri A, Battisti C, Monti L, Bonifati V, Rasi F, Federico A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cation Transport Proteins
Share to Longitudinal Studies
Share to Metabolic Diseases
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Parkinsonian Disorders

Share to Zinc Transporter 8

Source

Open in PubMed

Identifiers

PMID: 24276520
DOI: 10.1007/s00415-013-7187-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations.PMID 24276520Read ↗

Fifteen-year longitudinal follow-up of a patient with severe early-onset Charcot-Marie-Tooth disease type 2A.Semantic proximity Read ↗

Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder.Semantic proximity Read ↗

"Alternating" the Diagnosis after 40 Years of Disease: The Thousand Faces of ATP1A3 Mutation.Semantic proximity Read ↗

Phenotype of the 202 adenine deletion in the parkin gene: 40 years of follow-up.Semantic proximity Read ↗

Manganese Neurotoxicity: A Comprehensive Review of Pathophysiology and Inherited and Acquired DisordersSemantic proximity Read ↗

Manganese transport disorder: novel SLC30A10 mutations and early phenotypes.Semantic proximity Read ↗

Gaucher disease: lessons from a decade of therapy.Semantic proximity Read ↗

Comment: CAG repeats in idiopathic Parkinson disease-To screen or not to screen.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.